SCHOTT Pharma AG & Co. KGaA (FRA: 1SXP)
Germany
· Delayed Price · Currency is EUR 23.12
+0.08 (0.34%)
At close: Feb 4, 2025
FRA:1SXP Cash Flow Statement
Financials in millions EUR. Fiscal year is October - September.
Millions EUR. Fiscal year is Oct - Sep.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 |
| Net Income | 149.69 | 151.84 | 125.38 | 100.75 | 77.48 |
| Depreciation & Amortization | 64.98 | 51.85 | 43.79 | 36.44 | 33.73 |
| Loss (Gain) From Sale of Assets | -0.59 | -0.39 | -1.51 | -0.3 | -0.72 |
| Asset Writedown & Restructuring Costs | - | -5.2 | 11.57 | - | - |
| Loss (Gain) From Sale of Investments | -1.36 | -0.69 | - | - | - |
| Loss (Gain) on Equity Investments | 4.25 | 2 | - | - | - |
| Other Operating Activities | -4.11 | -2.93 | 27.01 | 10.57 | 4.52 |
| Change in Accounts Receivable | -16.96 | -32.43 | -35.57 | -18.5 | -19.68 |
| Change in Inventory | -3.41 | -15.38 | -30.64 | -19.06 | -12.12 |
| Change in Accounts Payable | 8.47 | -3.9 | 29.11 | 0.87 | 14.36 |
| Change in Unearned Revenue | 17.48 | 28.63 | 25.42 | 20.67 | 7.14 |
| Change in Other Net Operating Assets | 11.13 | 7.42 | -15.59 | -0.97 | 1.13 |
| Operating Cash Flow | 225.33 | 181.65 | 182.12 | 132.21 | 104.4 |
| Operating Cash Flow Growth | 24.04% | -0.26% | 37.75% | 26.64% | - |
| Capital Expenditures | -145.08 | -175.47 | -152.01 | -98.07 | -85.17 |
| Sale of Property, Plant & Equipment | 1.51 | 4.78 | 12.36 | 1.21 | 2.84 |
| Sale (Purchase) of Intangibles | -0.22 | -0.06 | -0.68 | -0.35 | -0.14 |
| Investment in Securities | -2.14 | -0.66 | -1.81 | -1.35 | - |
| Other Investing Activities | - | - | - | 2.68 | 1.25 |
| Investing Cash Flow | -145.93 | -171.41 | -142.14 | -95.89 | -81.22 |
| Long-Term Debt Issued | - | - | 1.04 | - | 0.65 |
| Long-Term Debt Repaid | -4.1 | -4.25 | -1.54 | -1.59 | -0.89 |
| Net Debt Issued (Repaid) | -4.1 | -4.25 | -0.5 | -1.59 | -0.24 |
| Common Dividends Paid | -22.59 | -18.88 | -11.46 | -39.82 | -44.04 |
| Other Financing Activities | -51.46 | 11.73 | -30.43 | 13.91 | 29.84 |
| Financing Cash Flow | -78.16 | -11.4 | -42.38 | -27.51 | -14.45 |
| Foreign Exchange Rate Adjustments | -2.42 | -3.28 | 3.33 | 0.44 | -5.78 |
| Miscellaneous Cash Flow Adjustments | - | - | - | 0 | - |
| Net Cash Flow | -1.18 | -4.44 | 0.94 | 9.25 | 2.95 |
| Free Cash Flow | 80.25 | 6.19 | 30.11 | 34.14 | 19.22 |
| Free Cash Flow Growth | 1197.51% | -79.46% | -11.80% | 77.60% | - |
| Free Cash Flow Margin | 8.38% | 0.69% | 3.67% | 5.26% | 3.29% |
| Free Cash Flow Per Share | 0.53 | 0.04 | 0.20 | 0.23 | 0.13 |
| Cash Interest Paid | 10.57 | 6.66 | 1.8 | 1.16 | 1.53 |
| Cash Income Tax Paid | 29.73 | 31.68 | 29.77 | 21.4 | 15.12 |
| Levered Free Cash Flow | -70.46 | 72.63 | -201.87 | -21.3 | - |
| Unlevered Free Cash Flow | -62.47 | 76.79 | -200.55 | -20.56 | - |
| Change in Net Working Capital | 100.24 | -93.24 | 196.7 | 30.14 | - |
Source: S&P Capital IQ. Standard template. Financial Sources.